Biosafety Assay Development
The development and use of a validated assay for a biopharmaceutical product is a critical part of the product
development process. Cambridge Biomedical is fully equipped and staffed to provide all services necessary to
produce a GLP or CLIA validated assay for your preclinical and clinical studies.
Our specific areas of expertise include: de novo assay development, assay technology transfer, optimization and
validation of novel or commercially available kits. We work with biological matrices from humans or animals as well as both small and large therapeutic molecules.
Our development capabilities are supported by a CLIA certified, CAP accredited laboratory capable of
processing 10 or 10,000 samples.
Methods and Technologies
We seamlessly adapt to your needs, bringing experience with most assay development methods and technologies including:
PCR, ELISA, MSD, RIA, HPLC, cell based assays, IHC, Luminex®, and flow cytometry.